Our study group has conducted NBS for CPT II deficiency as a pilot study since 2004 and as part of the nationwide healthcare service since 2018, in Japan, where the potentially fatal hypoglycemic form is apparently predominant, and the disease has been confirmed in 20 of 70 NBS-positive infants. Here, CPT2 is linked to hyperinsulinemic hypoglycemia, familial, 4.